OF ANOTHER PERSON COLD FRONT OVER THE
NEXT WEEK. SILENT WEEK. NEXT WEEK. QUIET WEEK. A LITTLE ON THE WARM SIDE. QUIET WEEK. A LITTLE ON THE COZY SIDE.
>>> > > > PRESCRIPTION DRUG RATES ARE A LITTLE ON THE COZY SIDE.
>>> > > > PRESCRIPTION MEDICINE PRICES ARE
ESCALATING IN FLORIDA. >>> > > > PRESCRIPTION DRUG RATES ARE
INCREASING IN FLORIDA. NAME-BRAND MEDICATION USED TO SKYROCKETING IN FLORIDA. NAME-BRAND DRUG USED TO
BEAT CANCER CELLS, DIABETIC ISSUES, ASTHMA NAME-BRAND MEDICATION USED TO
BEAT CANCER, DIABETES MELLITUS, BRONCHIAL ASTHMA
AS WELL AS SO LOTS OF OTHER CONDITIONS BEAT CANCER CELLS, DIABETES MELLITUS, ASTHMA
AND ALSO SO LOTS OF OTHER CONDITIONS
HAVE INCREASED AS HIGH AS 73% THEREFORE LOTS OTHER PROBLEMS
HAVE ACTUALLY INCREASED AS HIGH AS 73%.
CONSIDERING THAT 2015. HAVE INCREASED AS MUCH AS 73%.
BECAUSE 2015.
>>> > Alex: IN TODAY’S HEALTHCAST, GIVEN THAT 2015.
>>> > Alex: IN TODAY’S HEALTHCAST,.
WE APPEARANCE AT A SECRET VARIABLE THAT >>> > Alex: IN TODAY’S HEALTHCAST,.
WE CHECK OUT A TRICK ASPECT THAT.
SPIKES AND ALSO HAS AN IMPACT IN WE TAKE A LOOK AT A TRICK FACTOR THAT.
SPIKES AND ALSO HAS AN IMPACT IN.
HAVING– SEEING TO IT THAT SPIKES AND HAS AN EFFECT IN.
HAVING– SEEING TO IT THAT.
INDIVIDUALS GET THE VITAL DRUGS HAVING– MAKING CERTAIN THAT.
INDIVIDUALS OBTAIN THE IMPORTANT MEDICINE.
THAT THEY NEED.PEOPLE OBTAIN THE IMPORTANT DRUG. THAT THEY DEMAND.
> > Reporter: AS EXEC THAT THEY NEED. > > Press reporter: AS EXECUTIVE.
>>DIRECTOR OF THE NATIONAL > >
Press reporter: AS EXECUTIVE. SUPERVISOR OF THE NATIONAL.
MULTIPLE SCLEROSIS STRUCTURE, DIRECTOR OF THE NATIONAL. MULTIPLE SCLEROSIS STRUCTURE,.
NATALIE BLAKE HAS SEEN INDIVIDUALS MULTIPLE SCLEROSIS STRUCTURE,. NATALIE BLAKE HAS SEEN CLIENTS.
FACE THE HIGH PRICE OF DEALING NATALIE
BLAKE HAS SEEN PEOPLE. FACE THE HIGH PRICE OF HANDLING.
WITH THIS CONDITION.
FACE THE HIGH PRICE OF HANDLING. WITH THIS DISEASE.
> > THE AVERAGE EXPENSE OF
>> THE WITH THIS CONDITION. > > THE STANDARD PRICE OF THE. ILLNESS MODIFYING MEDICATIONS FOR MS > > THE STANDARD PRICE OF THE. DISEASE MODIFYING MEDICATIONS FOR MS. IS 60,000 A YEAR.
DISEASE CUSTOMIZING DRUGS FOR MS. IS 60,000 A YEAR.
> > Kristi: CLIMB IN>>THE RATE OF IS 60,000 A YEAR. > > Kristi: INCREASE IN THE
>>RATE OF. ALL KINDS OF MEDICINE SCHEDULES >>> > Kristi: INCREASE IN THE COST OF.
ALL KINDS OF MEDICINE SCHEDULES.
PARTLY OF DRUG STORE BENEFIT ALL KINDS OF MEDICINE IS FEE.
PARTLY OF DRUG STORE ADVANTAGE.
SUPERVISORS OR PDMs.IN PART OF DRUG STORE BENEFIT. SUPERVISORS OR PDMs.
> > DRUG STORE ADMINISTRATION MANAGERS MANAGERS OR PDMs. > > PHARMACY ADMINISTRATION MANAGERS.
>> WERE ARCHITECTED YEARS EARLIER OF > >
DRUG STORE ADMINISTRATION MANAGERS. WERE >> ARCHITECTED YEARS AGO OF.
IT PROMOTING THE ASSERTS
WERE ARCHITECTED YEARS AGO OF. IT HELPING WITH THE ASSERTS
. DEAL ON THE DRUG STORE IT ASSISTING IN THE ASSERTS. PURCHASE ON THE PHARMACY. COUNTER WITH THEIR INSURANCE COVERAGE DEAL ON THE PHARMACY. COUNTER WITH THEIR INSURANCE.
COMPANY. COUNTER WITH THEIR INSURANCE COVERAGE. COMPANY. > > Reporter: INITIALLY INTENDED
>>COMPANY. > > Reporter: INITIALLY INTENDED>>. TO CONTROL MEDICATION COSTS AS WELL AS > > Press Reporter: INITIALLY INTENDED. TO >>CONTROL DRUG COSTS AND.
ACCESSIBLE.TO CONTROL DRUG PRICES AND ALSO.
AVAILABLE.
RATES EXPERTS CLAIM THESE MIDDLE ACCESSIBLE. PRICES EXPERTS CLAIM THESE MIDDLE. MALES BETWEEN MEDICINE SUPPLIERS PRICING EXPERTS SAY THESE MIDDLE. MALES BETWEEN DRUG SUPPLIERS.
AND INSURER ARE GUY IN BETWEEN MEDICINE MAKERS. AND ALSO INSURANCE PROVIDER ARE.
INCREASING THE EXPENSES OF AND ALSO INSURANCE PROVIDER ARE. DRIVING UP THE EXPENSES OF. PRESCRIPTION MEDICINES. DRIVING UP THE COST OF.
PRESCRIPTION MEDICATIONS. > > PBM WERE PAID BY MEDICINE PRESCRIPTION DRUGS.
>> > > PBM WERE PAID BY MEDICINE. PRODUCERS.
>> > > PBM WERE PAID BY MEDICATION.
MAKERS.
>> BEGAN OPENING THEIR OWN
MANUFACTURERS. STARTED OPENING THEIR OWN. DRUG STORES.
STARTED OPENING THEIR OWN.
PHARMACIES. INSTEAD OF WORKING TO CONTROL PHARMACIES. INSTEAD OF WORKING TO CONTROL.
THE RATE OF THE PURCHASE, AS OPPOSED TO WORKING TO CONTROL.
THE PRICE OF THE DEAL,.
BEGAN PROFITING OFF OF THE THE PRICE OF THE TRANSACTION,.
BEGAN PROFITING OFF OF THE.
TRANSACTION. BEGAN PROFITING OFF OF THE.
PURCHASE.
>> > > ACCORDING TO SAT AFIRED, TRANSACTION.
>> > > ACCORDING TO SAT AFIRED,.
THREE PBMs IF CONTROL 80% OF THE >> > > BASE ON SAT AFIRED,.
3 PBMs IF CONTROL 80% OF THE.
MEDICATION PURCHASES. 3 PBMs IF CONTROL 80% OF THE.
MEDICATION TRANSACTIONS. WHILE THESE PBMs. MEDICATION TRANSACTIONS. WHILE THESE PBMs.
$ 82 BILLION. WHILE THESE PBMs.
$ 82 BILLION. THEY PROGRAM 2% OF THOSE DISCOUNTS $82 BILLION. THEY SHOW 2% OF THOSE REBATES.
WERE PASSED ON TO THE CUSTOMER THEY SHOW 2% OF THOSE DISCOUNTS.
WERE HANDED DOWN TO THE CONSUMER.
IN THE TYPE OF LOWER PRICE.WERE PASSED
ON TO THE CONSUMER.
IN THE KINDS OF LOWER RATE. BLAKE, WHO HERSELF SUFFERS FROM IN THE TYPES OF LOWER PRICE. BLAKE, WHO HERSELF SUFFERS FROM.
BRONCHIAL ASTHMA, SAYS PBMs PROVIDE ACCESS BLAKE, THAT HERSELF SUFFERS FROM.
BRONCHIAL ASTHMA, Claims PBMs Give ACCESSIBILITY.
TO MEDICATION. ASTHMA, Claims PBMs Give GAIN ACCESS TO.
TO DRUG.
>> > > I GOT ON A MEDICATION FOR 5 TO MEDICINE.
>> > > I WAS ON A MEDICINE FOR FIVE.
YEARS. >> > > I WAS ON A MEDICATION FOR FIVE.
YEARS. I ARRIVE, AND ALSO THEY STATES IT YEARS. I OBTAIN THERE, AND THEY STATES IT.
NOT AUTHORIZED. I GET THERE, AS WELL AS THEY SAYS IT.
NOT AUTHORIZED.
>> > > A PUSH IS ON TO SEE HOW THE NOT AUTHORIZED.
>> > > A PUSH IS ON TO SEE HOW THE.
SYSTEM OPERATES. >> > > A PRESS IS ON TO SEE HOW THE.
SYSTEM OPERATES.
>> > > WE NEED TO RECALIBRATE AND ALSO SYSTEM RUNS.
>> > > WE DEMAND TO RECALIBRATE AND.
THEY NO LONGER REVENUE OFF OF THE >> > > WE DEMAND TO ALTER AND.
THEY NO LONGER PROFIT OFF OF THE.
RISING COST OF PHARMACEUTICAL THEY NO LONGER PROFIT OFF OF THE.
CLIMBING COST OF DRUG.
AND ALSO WHEN THEY SUCCESSFULLY LOWER RISING COST OF DRUG.
AS WELL AS WHEN THEY EFFICIENTLY LOWER.
THAT PRICES OF DRUG AND ALSO PASS AND ALSO WHEN THEY EFFICIENTLY REDUCED.
THAT PRICES OF DRUG AND PASS.
THOSE FINANCIAL SAVINGS ON TO CONSUMERS.THAT EXPENSE OF DRUG AND PASS. THOSE SAVINGS ON CONSUMERS. > > Kristi: THE MS FOUNDATION AS THOSE>>COST SAVINGS ON CONSUMERS. > > Kristi: THE MS FOUNDATION AS>. WELL AS OTHER TEAMS HAVE CALLED
> > Kristi: THE MS STRUCTURE AS. WELL AS >>OTHER TEAMS HAVE ACTUALLY CALLED.
ON THE FEDERAL TRADE COMMISSION WELL AS OTHER GROUPS HAVE CALLED. ON THE FEDERAL PROFESSION COMPENSATION. TO INVESTIGATE THE EFFECT ON THE FEDERAL TRADE PAYMENT. TO EXPLORE THE EFFECT.
THESE PBMs HAVE ON MILLIONS OF TO INVESTIGATE THE IMPACT. THESE PBMs HAVE ON MILLIONS OF.
AMERICANS TO BOOST PATIENT THESE
PBMs Carry COUNTLESS. AMERICANS TO ENHANCE INDIVIDUAL.
ACCESS AND PRICE TO.
